Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex
Authors
G. Sava
I. Capozzi
K. Clerici
G. Gagliardi
E. Alessio
G. Mestroni
Publication date
01-05-1998
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 4/1998
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006521715400

Other articles of this Issue 4/1998

Clinical & Experimental Metastasis 4/1998 Go to the issue

OriginalPaper

Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer

OriginalPaper

Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride

OriginalPaper

Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer

OriginalPaper

Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis

OriginalPaper

TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span

OriginalPaper

Inhibition of VLA-4 and up-regulation of TIMP-1 expression in B16BL6 melanoma cells transfected with MHC class I genes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits